Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy Volunteers
Crossref DOI link: https://doi.org/10.1007/s40261-016-0485-9
Published Online: 2016-12-02
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Salem, Ahmed Hamed http://orcid.org/0000-0002-9261-1583
Hu, Beibei
Freise, Kevin J.
Agarwal, Suresh K.
Sidhu, Dilraj S.
Wong, Shekman L.
Funding for this research was provided by:
AbbVie
Genentech
License valid from 2016-12-02